A noninvasive and highly efficient epigenetic predictive model for efficacy of the GOLP regimen in patients with intrahepatic cholangiocarcinoma
Xian‐Long Meng(Fudan University), Lei Yu(Taiyuan Central Hospital), Xiaoyong Huang(Fudan University), S. Hu(Sun Yat-sen University), Qiang Gao(Northeastern University), Yixiang Shi(Viva Biotech (China)), Ying‐Hao Shen(Fudan University), Mu Ye(Sun Yat-sen University), Jia‐Cheng Lu(Fudan University), Jiabin Cai(Fudan University), Xiaojun Guo(China Banking Regulatory Commission), Liang Chen(Fudan University), Wei Zhang(Hebei North University), Xiaolan Wang(Jiujiang Maternal and Child Care Centres), Chuan He(University of Chicago), Jia Fan(Fudan University), Zhiqiang Hu(Southern Medical University), Jian Zhou(Southeast University), Qi‐Man Sun(Ministry of Education of the People's Republic of China), Xiaolong Cui(Second Affiliated Hospital of Nanjing Medical University), Pei Pu(Sun Yat-sen University)
Cited by 3
Related Papers
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
|Nature Metabolism|2023|540
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2019|387